Markers of systemic inflammatory response, oxidative stress, and endothelial dysfunction in patients with arterial hypertension combined with rheumatoid arthritis with diastolic dysfunction

Authors

  • Nataliya Ryndina State Institution “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine” Vintera blvd., 20, Zaporizhzhia, Ukraine, 69096, Ukraine https://orcid.org/0000-0002-8060-3789

DOI:

https://doi.org/10.15587/2519-4798.2019.179350

Keywords:

rheumatoid arthritis, arterial hypertension, diastolic function of the left ventricle, lipid peroxidation, endothelial dysfunction

Abstract

Introduction. In patients with rheumatoid arthritis (RA) in combination with arterial hypertension (AH) the early development of cardiovascular complications is caused by chronic systemic inflammation, a high level of pro-inflammatory cytokines and lipid peroxidation products (LPO).

Aim of the research. For the purpose of early diagnosis of complications, study of the diastolic function of the left ventricle (LV) in patients with AH in combination with RA and determine the predictor value of LPO, endothelial function (EF), markers of a systemic inflammatory response regarding impaired LV diastolic function, and detection of exudate in the pericardial cavity.

Materials and methods. We examined 96 patients with stage II of AH in combination with RA, 45 patients with stage II arterial hypertension and 31 healthy subjects. Patients underwent echocardioscopy and we determined the levels of isolated double bonds, Schiff’s bases, diene conjugates, diene ketones, malonic aldehyde, vitamins A, E, catalase, asymmetric dimethylargenini (ADMA), interleukin-1 beta (IL 1-B), interleukin-10 ( IL 10), a highly sensitive C-reactive protein (hs-CRP) and the level of final serum nitric oxide metabolites.

Conclusins. The highest predictor value with respect to impaired LV diastolic function in AH patients in combination with RA was found in the indicator IL 1-B, AUC 0.882, sensitivity 72.15%, specificity 100% with an optimal distribution point >9.67 pg / ml, and relatively for detecting fluid in the pericardial cavity at an ADMA AUC of 0.913 with an optimal distribution point >0.841 μmol / L, sensitivity 94.12%, specificity 85.53%

Author Biography

Nataliya Ryndina, State Institution “Zaporizhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine” Vintera blvd., 20, Zaporizhzhia, Ukraine, 69096

Postgraduate Student

Department of Therapy of Clinical Pharmacology and Endocrinology

References

  1. Holmqvist, M., Ljung, L., Askling, J. (2017). Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks. Annals of the Rheumatic Diseases, 76 (10), 1642–1647. doi: http://doi.org/10.1136/annrheumdis-2016-211066
  2. Dougados, M., Soubrier, M., Antunez, A., Balint, P., Balsa, A., Buch, M. H. et. al. (2013). Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Annals of the Rheumatic Diseases, 73 (1), 62–68. doi: http://doi.org/10.1136/annrheumdis-2013-204223
  3. Avina-Zubieta, J. A., Thomas, J., Sadatsafavi, M., Lehman, A. J., Lacaille, D. (2012). Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Annals of the Rheumatic Diseases, 71 (9), 1524–1529. doi: http://doi.org/10.1136/annrheumdis-2011-200726
  4. Del Rincón, I., Polak, J. F., O’Leary, D. H., Battafarano, D. F., Erikson, J. M., Restrepo, J. F. et. al. (2014). Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Annals of the Rheumatic Diseases, 74 (6), 1118–1123. doi: http://doi.org/10.1136/annrheumdis-2013-205058
  5. Veselinovic, M., Barudzic, N., Vuletic, M., Zivkovic, V., Tomic-Lucic, A., Djuric, D., Jakovljevic, V. (2014). Oxidative stress in rheumatoid arthritis patients: relationship to diseases activity. Molecular and Cellular Biochemistry, 391 (1-2), 225–232. doi: http://doi.org/10.1007/s11010-014-2006-6
  6. Mason, J. C., Libby, P. (2014). Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions. European Heart Journal, 36 (8), 482–489. doi: http://doi.org/10.1093/eurheartj/ehu403
  7. Aslam, F., Bandeali, S. J., Khan, N. A., Alam, M. (2013). Diastolic Dysfunction in Rheumatoid Arthritis: A Meta-Analysis and Systematic Review. Arthritis Care & Research, 65 (4), 534–543. doi: http://doi.org/10.1002/acr.21861
  8. Tomáš, L., Lazúrová, I., Oetterová, M., Pundová, L., Petrášová, D., Studenčan, M. (2013). Left ventricular morphology and function in patients with rheumatoid arthritis. Wiener Klinische Wochenschrift, 125 (9-10), 233–238. doi: http://doi.org/10.1007/s00508-013-0349-8
  9. Pujades-Rodriguez, M., Duyx, B., Thomas, S. L., Stogiannis, D., Rahman, A., Smeeth, L., Hemingway, H. (2016). Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England. PLOS ONE, 11 (3), e0151245. doi: http://doi.org/10.1371/journal.pone.0151245
  10. Pro zatverdzhennia ta vprovadzhennia medyko-tekhnolohichnykh dokumentiv zi standartyzatsii medychnoi dopomohy pry revmatoidnomu artryti: MOZ Ukrainy No. 263. 11.04.2014. Available at: http://old.moz.gov.ua/ua/portal/dn_20140411_0263.html
  11. Lang, R. M., Badano, L. P., Mor-Avi, V., Afilalo, J., Armstrong, A., Ernande, L. et. al. (2015). Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. European Heart Journal – Cardiovascular Imaging, 16 (3), 233–271. doi: http://doi.org/10.1093/ehjci/jev014
  12. Crowson, C. S., Rollefstad, S., Ikdahl, E., Kitas, G. D., van Riel, P. L. C. M., Gabriel, S. E. et. al. (2017). Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 77 (1), 48–54. doi: http://doi.org/10.1136/annrheumdis-2017-211735
  13. Arts, E. E., Fransen, J., Den Broeder, A. A., van Riel, P. L. C. M., Popa, C. D. (2017). Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study. Annals of the Rheumatic Diseases, 76 (10), 1693–1699. doi: http://doi.org/10.1136/annrheumdis-2016-210997
  14. Innala, L., Möller, B., Ljung, L., Magnusson, S., Smedby, T., Södergren, A. et. al. (2011). Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Research & Therapy, 13 (4), R131. doi: http://doi.org/10.1186/ar3442
  15. Willeit, P., Freitag, D. F., Laukkanen, J. A., Chowdhury, S., Gobin, R., Mayr, M. et. al. (2015). Asymmetric Dimethylarginine and Cardiovascular Risk: Systematic Review and Meta‐Analysis of 22 Prospective Studies. Journal of the American Heart Association, 4 (6). doi: http://doi.org/10.1161/jaha.115.001833

Downloads

Published

2019-10-10

How to Cite

Ryndina, N. (2019). Markers of systemic inflammatory response, oxidative stress, and endothelial dysfunction in patients with arterial hypertension combined with rheumatoid arthritis with diastolic dysfunction. ScienceRise: Medical Science, (5 (32), 4–10. https://doi.org/10.15587/2519-4798.2019.179350

Issue

No. 5 (32) (2019)

Section

Medical Science

License

Copyright (c) 2019 Nataliya Ryndina

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.